Tupá Veronika, Drahošová Slávka, Grendár Marián, Adamkov Marian
Comenius University in Bratislava, Jessenius Faculty of Medicine in Martin, Department of Histology and Embryology, Malá Hora 4, 036 01, Martin Slovakia.
Hermes LabSystems, s.r.o., Púchovská 12, 83106, Bratislava, Slovakia.
Pathol Res Pract. 2019 Apr;215(4):705-711. doi: 10.1016/j.prp.2019.01.012. Epub 2019 Jan 7.
This work was designed to determine the relationship between hypoxia-inducible protein carbonic anhydrase IX (CA IX) and pro-inflammatory enzyme cyclooxygenase-2 (COX-2) in patients with colorectal cancer (CRC).
We examined CA IX and COX-2 expression in CRC tissues by immunohistochemical staining of 111 samples. We evaluated the correlation between the expression of these proteins and their correlation with the clinico-morphological parameters of CRC.
CA IX was detected in 89 of 111 cases (80.2%). We predominantly observed membrane staining (70.3%) and a strong immunoreaction intensity (58.6%). The percentage of labeled cells in malignant lesions was less than 25% in 12.6% of cases, less than 50% in 15.3% of cases and more than 50% in 52.3% of CRC cases. The COX-2 protein was expressed in 94 of 111 cases (84.7%). We noticed only cytoplasmic localization, while immunoreaction intensity was predominantly strong (47.8%). The percentage of COX-2 positive cells was less than 25% only in 2.7% of the cases, less than 50% in 21.6% of the cases and more than 50% in 60.4% of the cases. No statistically significant correlations were observed between CA IX expression and clinico-morphological parameters. COX-2 expression was only significantly correlated with the tumor stage. Statistical analysis confirmed a significant correlation between the parameters of expression of the CA IX and COX-2 proteins.
CA IX/COX-2 interplay can promote hypoxia survival and the invasion of tumor cells. These proteins may represent independent prognostic factors of CRC.
本研究旨在确定结直肠癌(CRC)患者中缺氧诱导蛋白碳酸酐酶IX(CA IX)与促炎酶环氧合酶-2(COX-2)之间的关系。
我们通过对111份样本进行免疫组织化学染色,检测CRC组织中CA IX和COX-2的表达。我们评估了这些蛋白表达之间的相关性及其与CRC临床形态学参数的相关性。
111例病例中有89例(80.2%)检测到CA IX。我们主要观察到膜染色(70.3%)和强免疫反应强度(58.6%)。在12.6%的病例中,恶性病变中标记细胞的百分比小于25%,在15.3%的病例中小于50%,在52.3%的CRC病例中大于50%。COX-2蛋白在111例病例中的94例(84.7%)中表达。我们仅注意到细胞质定位,而免疫反应强度主要为强(47.8%)。COX-2阳性细胞的百分比仅在2.7%的病例中小于25%,在21.6%的病例中小于50%,在60.4%的病例中大于50%。未观察到CA IX表达与临床形态学参数之间存在统计学显著相关性。COX-2表达仅与肿瘤分期显著相关。统计分析证实CA IX和COX-2蛋白表达参数之间存在显著相关性。
CA IX/COX-2相互作用可促进缺氧状态下肿瘤细胞的存活和侵袭。这些蛋白可能代表CRC的独立预后因素。